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Summary
The zebrafish fat-free (ffr) mutation was identified in a physiological screen for genes that regulate lipid metabolism. ffr
mutant larvae are morphologically indistinguishable from wild-type sibling larvae, but their absorption of fluorescent lipids
is severely impaired. Through positional cloning, we have identified a causative mutation in a highly conserved and ubiqui-
tously expressed gene within the ffr locus. The Ffr protein contains a Dor-1 like domain typical of oligomeric Golgi complex
(COG) gene, cog8. Golgi complex ultrastructure is disrupted in the ffr digestive tract. Consistent with a possible role in COG-
mediated Golgi function, wild-type Ffr-GFP and COG8-mRFP fusion proteins partially colocalize in zebrafish blastomeres.
Enterocyte retention of an endosomal lipid marker in ffr larvae support the idea that altered vesicle trafficking contributes
to the ffr mutant defect. These data indicate that ffr is required for both Golgi structure and vesicular trafficking, and ulti-
mately lipid transport.Introduction
Dietary fat consumption is known to be a risk factor in cardio-
vascular diseases, diabetes, and obesity (Hill et al., 2003; Joffe
et al., 2001; McNeely et al., 2001). In recent years, significant ef-
fort has been applied to defining basic mechanisms whereby
cholesterol and other lipids are absorbed and transported by
small intestinal enterocytes. Despite recent advances, many
features of this process remain undefined (Cao et al., 2003; Ehe-
halt et al., 2004a, 2004b; Field, 2001; Pohl et al., 2004; Tso and
Fujimoto, 1991). Heritable diseases associated with alteration of
lipid absorption can perturb either digestion and uptake of die-
tary lipids or their transport and subsequent export into the lym-
phatic system and bloodstream as lipoprotein particles or pro-
tein-bound lipids. Recently, causative mutations in genes that
play a role in intracellular trafficking have been identified for sev-
eral of these latter groups of disorders (Chang et al., 2005; Jones
et al., 2003; Orso et al., 2000; Soutar et al., 2003).
In previous work, we showed that fluorescent reporters can
serve as optical biosensors that can be used in high-throughput
genetic screens to identify genes that regulate lipid metabolism
(Farber et al., 2001). In a pilot screen using the quenched fluo-
rescent phospholipid PED6, we identified a recessive lethal mu-
tation in fat free (ffr) that alters processing of several classes of
lipid compounds. ffr mutant larvae swallow normally but have
limited absorption of phospholipids, cholesterol, and long-chain
fatty acids compared with wild-type siblings. Initial biochemical
analysis suggested that altered bile synthesis or secretion may
account for this lipid absorption defect (Farber et al., 2001; Ho
et al., 2003).
Here, we describe a more detailed phenotypic analysis of ffr
mutant larvae and the positional cloning of the ffr gene. ffr en-CELL METABOLISM 3, 289–300, APRIL 2006 ª2006 ELSEVIER INC. Dcodes a conserved protein with no known function that is ex-
pressed in a wide range of eukaryotic organisms. The only rec-
ognizable feature of the protein is a small domain homologous to
the Dor-1 region of a conserved gene that is a component of the
COG complex (Ungar et al., 2002). This hetero-octomeric pro-
tein complex regulates Golgi structure and vesicle traffic be-
tween the Golgi and the endoplasmic reticulum (ER) in yeast
and mammalian cells (Oka et al., 2004, 2005; Ram et al., 2002;
Suvorova et al., 2002; Ungar et al., 2005; VanRheenen et al.,
1998). Saccharomyces cerevisiae dor-1, a COG component, is
essential for vesicle targeting to the Golgi (Whyte and Munro,
2001), whereas the mammalian Dor-1 ortholog Cog8 has been
proposed to regulate intra-Golgi transport and secondary pro-
tein glycosylation (Ungar et al., 2002). Consistent with a role
for Ffr in intracellular trafficking and Golgi function, we show
that a Ffr-GFP fusion protein partially colocalizes with Cog8
and that an ApoA1 fusion protein is mislocalized in ffr-deficient
zebrafish embryos. In addition, wild-type Ffr protein localizes
in part to the TGN, while mutant Ffr protein, which has an intact
Dor-1-like domain, is restricted to the TGN. Endosomal labeling
experiments using the styryl dye AM1-43 also show that vesic-
ular recycling is impaired in ffr mutants. These data, together
with observations of altered intestinal Golgi ultrastructure in ffr
mutants, support the idea that Ffr is an important mediator of in-
testinal lipid absorption through its effects on intracellular traf-
ficking and protein secretion.
Results
Zebrafish ffr mutants exhibit digestive system defects
Homozygous ffr mutant larvae are morphologically indistin-
guishable from wild-type siblings at 5 days postfertilizationOI 10.1016/j.cmet.2006.03.001 289
A R T I C L EFigure 1. Phenotypic analysis of ffr mutants
A and B) Confocal projections through the liver of 5 dpf wild-type and ffr larvae processed for cytokeratin immunohistochemistry. These immunostainings reveal wide-
spread biliary degeneration in ffr mutants (5 dpf).
C and D) Similar immunostainings of 5 dpf wild-type and ffr larvae processed for p-glycoprotein immunohistochemistry. These images of the wild-type and ffr liver show
that canalicular architecture is also disrupted in the ffr mutants (5 dpf).
E and F) Transmission electron micrographs showed degenerating biliary epithelial cells (bc) (indicated by arrow) and canaliculi (indicated by arrowhead) within the liver of
ffr mutants (F) compared with wild-type (E).
G and H) Electron micrographs of the pancreas reveal small zymogen granules in the ffr mutants (arrowhead; [H]) compared with wild-type (G).
I and J) Confocal image from the pancreas of a 5 dpf ffr mutant (J) processed for carboxypeptidase A immunohistochemistry (green) showed altered distribution of this
digestive enzyme compared with wild-type (I). Nuclei stained with Dapi (blue).(dpf), the onset of exogenous feeding. However, ffr mutants fail
to process fluorescently labeled phosphatidylcholine (PC), long-
chain fatty acid and cholesterol analogs ingested at this devel-
opmental stage (Farber et al., 2001). To better understand the
lipid processing defect caused by the ffr mutation, we per-
formed histological and ultrastructural analyses of the digestive
organs of ffr mutant larvae.
Liver and biliary anatomies were characterized first, because
of the important role that bile plays in dietary lipid absorption.
Hepatocytes appear normal in histological sections and elec-
tron micrographs (data not shown). Immunostainings with an
antibody directed against a cytokeratin biliarymarker (Figure 1B)
and with a mammalian canalicular marker, p-glycoprotein
(Figure 1D), were markedly abnormal compared to wild-type
(Figures 1A and 1C). Ultrastructural analysis showed paucity
of intrahepatic bile ducts with degeneration of most remaining
biliary epithelial cells (Figures 1E and 1F). These initial findings290suggested that the ffr gene is essential for the maintenance or
development of the intrahepatic biliary system.
Further analyses revealed additional ultrastructural defects
throughout the ffrdigestive system.Zymogengranuleswithin ac-
inar cells of the ffr exocrine pancreas were small (Figure 1H), and
the digestive enzyme carboxypeptidase A was mislocalized
(Figure 1J) in comparison to wild-type siblings (Figures 1G and
1I) indicating a defect in protein sorting and/or processing. The
Golgi was also markedly dilated in ffr mutant intestinal entero-
cytes and surviving biliary epithelial cells at 5 dpf (Figures 2A–2D
and 2G–2H). Less pronounced Golgi defects were present in in-
testinal enterocytes and biliary epithelial cells at earlier develop-
mental stages (4 dpf; data not shown) and within the pancreatic
exocrine cells (5 dpf; Figures 2Eand2F) aswell as hepatocytes (5
dpf; data not shown). By contrast, Golgi morphologywas normal
in kidney epithelia, skeletal muscle and endocrine pancreas
(data not shown). Together, these data suggested that the FfrCELL METABOLISM : APRIL 2006
Abnormal lipid trafficking in zebrafish ffr mutantsFigure 2. Ultrastructural analyses reveal abnormal Golgi apparatus in the ffr mutants
A–D) Transmission electron micrographs show that intestinal Golgi architecture is disrupted in in 5 dpf ffrmutant larvae (B and D) compared to wild-type larvae (A and C).
E–H)Golgi morphology is also disrupted in the 5 dpf ffr exocrine pancreas (F) and biliary cells (H), compared with wild-type (E andG) (5 dpf). n, nucleus; bd, bile duct lumen;
arrowheads point to Golgi in all panels.protein is essential for lipid processing and Golgi morphology
within the digestive tract.
Dor-1 (COG8) homology in Ffr
To identify the ffr gene, a positional strategywas employed. Bulk
segregant analysis using markers from the zebrafish genetic
map placed the ffr locus on zebrafish chromosome 10. In subse-
quent steps, a critical region surrounding the ffr locus bounded
by markers 1.1 cM (z54342) and 3.8 cM (z25936) from the ffr lo-
cus was defined. Additional studies identified a polymorphicCELL METABOLISM : APRIL 2006marker within an EST (fc83b07) that was 0.06 cM (1 recombinant
in 1732 meioses) from the ffr locus. Using this marker 5 BAC
clones containing sequences adjacent to the ffr locuswere iden-
tified. Based upon end sequences of these BAC clones, a fully
sequenced BAC (dK56F11) predicted to contain eight genes
was identified from the public zebrafish genome database (Fig-
ure 3A). Sequence analysis of the eight candidate cDNAs from
ffr mutant and wild-type sibling larvae identified only a single
point mutation within an open reading frame with high sequence
homology to the human gene ANG2 (Lemmens et al., 1997)Figure 3. Positional cloning of the zebrafish ffr locus
A) Schematic of the ffr locus. Marker fc83b07 is 0.06
cM from the ffr locus (1 recombinant out of 1732mei-
oses). A radiolabeled probe synthesized from
fc83b07 identified five BAC clones. Mapping using
the end sequences of these BAC clones indicated
that clone dK56F11 spanned the entire ffr locus.
B) A single nucleotide mutation (C to T) that results in
a premature stop codon was identified in ffrmutants
(0 recombinants > 2000 meioses) within a predicted
open reading of dK56F11.
C) Domain analysis indicates that Ffr has a Dor-1 like
domain, a tyrosine phosphorylation site (Tyr-P), and
a SGXG motif. The truncated mutant protein is pre-
dicted to be approximately half the length of wild-
type Ffr.
D) ffr is located on zebrafish chromosome 10 in a re-
gion syntenic to a region of human chromosome
11q13.291
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Abnormal lipid trafficking in zebrafish ffr mutantsFigure 5. Phenocopy of the ffr mutation by targeted morpholino antisense oligonucleotides and rescue of the phenotype by ffr mRNA injection
A)Genomic structure of the ffr gene. The white blocks represent the exons from 1–11. The morpholino antisense oligonucleotides were designed either targeting the AUG
translation initiation codon (MO1) or at mRNA splice junctions (MO2, MO4, and MO5).
B and C). ffr mutants (6 dpf) exhibit altered lipid absorption. Lipid processing was visualized by labeling with fluorescent cholesterol (NBD-cholesterol, 2 hr, 3 mg/ml sol-
ubilized with fish bile). Gall bladder fluorescence is absent in the ffr larvae. The ffr larva in (B) was indistinguishable from wild-type.
DandE)Antisense targeting of ffr phenocopies themutant phenotype. Embryoswere injectedwith either water (control) or splice junctionMOs (morphant) at the 1- to 4-cell
stage. Larvae (5 dpf) were labeled with fluorescent cholesterol (NBD-cholesterol, 2 hr, 3 mg/ml solubilized with fish bile). Morphants exhibited decreased fluorescence in the
digestive system.
F) ffr mRNA injections can restore fluorescent cholesterol labeling of mutant larvae (p < 0.01). The offspring of heterozygous ffr parents were injected with ffr mRNA and
phenol red, or with water and phenol red (control) at the 1- to 4-cell stage. Injected larvae (5 dpf) were immersed in the embryo medium containing fluorescent cholesterol
(2 hr, 3 mg/ml solubilized with fish bile). Each larva was then photographed prior to molecular genotyping. Fluorescence intensity was digitally quantified as described in the
Experimental Procedures. Data represent mean 6 SEM.(Figure 3B). This C to T transition generated apremature stop co-
don in the zebrafish ang2 cDNA. Supporting the idea that zebra-
fish ang2 was in fact the ffr gene, 0 of 2000 ffrmutants were re-
combinant for a polymorphic marker identified within this
predicted gene. Further supporting ffr as an ANG2 ortholog,
the region adjacent to ffr is syntenic to human chromosome
11q13 (Figure 3D).
A comparison of the cDNA and genomic sequences revealed
that the ffr gene encodes a 2.5-kilobase transcript containing 11
exons. The predicted 842 amino acid zebrafish protein is well
conserved compared with its invertebrate and mammalian or-
thologs and overall has 75% identity to human ANG2 (Figure 4).
Analysis of the predicted amino acid sequence indicates that
Ffr contains a Dor-1 like domain, a canonical tyrosine phosphor-
ylation site, and a putative SGXGmotif (a potential glycosamino-
glycan attachment site) (Figure 3C).CELL METABOLISM : APRIL 2006To confirm that the ffr gene is responsible for the mutant
phenotype, ‘‘knockdown’’ experiments were performed using
nonoverlapping antisense morpholino oligonucleotides (MOs)
(Figure 5A). A morpholino designed to target the ffr translation
initiation codon (MO-1) was lethal even when injected into
1- to 4-cell stage wild-type embryos at low concentrations
(42–126 ng per embryo; data not shown). Several other MOs
were designed to target either splice donor (MO-2; MO-5) sites
or a splice acceptor (MO-4) site within newly transcribed zygotic
ffr mRNA. These splice blocking MOs act to disrupt zygotic
mRNA processing without interfering with maternal ffr mRNA
translation. The effectiveness of splice junction targeting by
MO4 was confirmed by RT-PCR (data not shown). Injection of
MO2, MO4 andMO5 phenocopied the ffr lipid absorption defect
in 80% of 5 dpf larvae (n = 20 from three experiments)
(Figure 5E).Figure 4. Zebrafish Ffr protein is highly conserved from invertebrate to human
A) The zebrafish Ffr protein sequence reveals 75% identity with human ortholog, and 46% identity with fly ortholog.
B) Dor-1 like domain (amino acids 41–384) was identified using a prosite motif scan (http://us.expasy.org/prosite/) and returned a hit to Dor-1 (amino acids 41–384, raw-
score = 2111.2, N-score = 11.150, E-value = 0.00015; pfam Dor1–Dor1-like family).293
A R T I C L EOverexpression studies with in vitro transcribed, capped ffr
mRNA, provided further evidence that mutation of the ffr gene
disrupts lipid metabolism in zebrafish larvae. wild-type ffrmRNA
was synthesized and injected into 1- to 4-cell stage embryos ob-
tained fromacrossof ffrheterozygotes. ffrmutant embryos (n=5
of 20 injected larvae) were indistinguishable from their wild-type
siblings following PED6 or fluorescent cholesterol labeling
(Figure 5F). Given that exogenousmRNA is rapidly degraded fol-
lowing injection into zebrafish embryos, these data suggest that
the Ffr protein has a long half-life in developing zebrafish.
Ffr localizes to the perinuclear region and TGN
In order to identify where the ffr gene is expressed, we first
attempted to detect its expression by whole-mount RNA in
situ hybridization. We also attempted to localize the protein us-
ingwhole-mount immunostaining with the zebrafish Ffr antibody
described above. However, the low signal/noise ratio make ffr
RNA hybridization or Ffr immunostaining signal indistinguish-
able from the nonspecific control (data not shown). We therefore
hypothesize that ffr is likely expressed at a low level in a wide-
spread fashion. Indeed, our microarray data were consistent
with the idea that ffr is expressed at low levels relative to b-actin
in developing zebrafish embryos and larvae (Figure 6A). Further,
we did detect ffr transcript ubiquitously expressed in adult ze-
brafish tissues by RT-PCR (Figure 6B).
Because Ffr has a Dor-1 like domain, we compared its ex-
pression and subcellular localization to COG8, another Dor-1
family protein that is reported to localize to the Golgi to regulate
intra-Golgi transport (Ungar et al., 2002). We also examined the
tissue distribution of human ffr. Human ffr and cog8 were ex-
pressed in all tissues tested (Figure 6C). Because both ffr and
cog8 contain a Dor-1 domain, we hypothesized that they coloc-
alize at the subcellular level. To test this hypothesis, mRNAs en-
coding a zebrafish Ffr-GFP fusion protein and a zebrafish
COG8-mRFP fusion protein were coinjected into newly fertilized
zebrafish embryos to overcome the low signal/noise ratio for ffr
detection. Injected embryos were imaged so that the fusion pro-
tein could be localized within individual blastomeres using con-
focal microscopy. The Ffr-GFP fusion protein was present in the
perinuclear region in a punctate pattern (Figure 6D) that partially
colocalized with COG8-mRFP which likely localized within the
Golgi (Ungar et al., 2002) (Figures 6E and 6F). We were able to
clearly image the large enveloping layer cells (the outermost
cell layer) that surround the embryo by confocal microscopy. In-
terestingly, mutant Ffr mRFP (Figures 6H and 6K) is restricted to
the TGN as indicated by its partial colocalization with Clathrin-
GFP (Figure 6J), an established Golgi marker (Gaidarov et al.,
1999). Wild-type Ffr-GFP (Figures 6D and 6G) colocalizes with
mutant Ffr -mRFP in the TGN. However, it is also is found in
perinuclear regions (Figures 6D and 6G). Microinjection of the
mRNA encoding the Ffr-GFP fusion protein did not rescue ffr
mutant larvae (data not shown).
Ffr regulates vesicle recycling and protein sorting
Golgi defects within ffr mutant digestive organs resemble Golgi
defects associated with mutations of COG complex genes
(Ungar et al., 2002). Although protein secretion is reported to
be normal in cells carrying COG gene mutations, protein glyco-
sylation within the Golgi of these cells is disrupted (Kingsley
et al., 1986). Lipid absorption defects in ffr mutants suggested
that Golgi-associated vesicular trafficking might also be im-294paired in ffr mutant larvae. To test this hypothesis, larvae (5
dpf) were fed AM1-43, a fixable form of a styryl dye (FM1-43)
commonly used to measure endocytosis (Brumback et al.,
2004). Following AM1-43 labeling, embryos ingested a selective
cyclodextran (ADVASEP-7) to remove noninternalized dye from
the plasmamembrane (Kay et al., 1999), thus allowing the fate of
labeled enterocytes to be followed histologically. ffr enterocytes
(Figures 7A, 7G, and 7I) had significantly more AM1-43-contain-
ing particles in their enterocytes than wild-type (Figures 7D, 7H,
and 7J) larvae. In addition, AM1-43-derived fluorescence in ffr
enterocytes was localized in enlarged perinuclear organelles
suggestive of dilated Golgi apparati (Figure 7C). These results
suggest that trafficking of endocytotic cargo is disrupted at
the level of the Golgi in ffr mutant enterocytes.
The Golgi complex is important not only for vesicular traffick-
ing during endocytosis but also for protein sorting and secretion.
To further assess Ffr function, we examined the processing of an
apolipoprotein A1-mRFP fusion protein in ffr2/2 zebrafish em-
bryos. In vitro transcribed apoAI-mrfp mRNA was injected into
1- to 4-cell stage embryos alone and in combination with low
doses of ffr MO-1. Following injections, embryos were fixed
and processed for confocal microscopy. ApoA1-mRFP was dif-
fusely distributed within the cytoplasm of ffr-deficient blasto-
meres (Figure 7L), whereas in wild-type embryos, ApoA1 was
clustered intracellularly (Figure 7K). These data further suggest
a role for Ffr in protein sorting.
Discussion
The absorption and transport of lipids by vertebrate cells is de-
pendent upon genes that regulate vesicular trafficking. TheGolgi
complex receives and sorts vesicular cargo derived from endo-
somes and ER and thus plays a central role in these processes.
In the intestine, the majority of dietary and biliary lipids traverse
the Golgi within chylomicrons and very low-density lipoprotein
particles that are formed in the ER or recycled from endo-
somes. From the Golgi, the lipoprotein particles are trans-
ported to the basolateral surface of the enterocyte and secreted
into the lymphatic system (Albers and Cheung, 2004; Field,
2001).
Altered lipid metabolism is a central feature of heritable hu-
man diseases that disrupt intracellular vesicular trafficking.
Tangier disease, an autosomal recessive disorder that arises
from defective efflux of cellular cholesterol, is caused by muta-
tions of the ABCA1 transporter, encoded by a gene that is es-
sential for the cellular efflux of phospholipids and cholesterol
via ApoAI (Soumian et al., 2005). Ultrastructural analyses sug-
gest that the ABCA1 transporter also regulates Golgi morphol-
ogy and function in ABCA1 knockout mice (Orso et al., 2000).
Mutations in the Sar1-GTPase, a protein that facilitates ER to
Golgi trafficking, have been reported in patients with heritable
disorders that are associated with severe fat malabsorption
(Jones et al., 2003). Here, we define a role in lipid metabolism
for a previously described vertebrate gene of unknown function
that is likely to be involved in intracellular vesicular trafficking
and Golgi morphology in zebrafish.
Several lines of evidence support our identification of the ze-
brafish ang2 ortholog, which we have renamed fat-free, as the
ffr gene. First, genemapping experiments place the ffrmutant lo-
cus within close proximity to the ang2 gene. Second, predicted
translation of the truncated protein encoded by the ffr geneCELL METABOLISM : APRIL 2006
Abnormal lipid trafficking in zebrafish ffr mutantsFigure 6. ffr expression and protein localization
A) Developmental profile of ffr expression. mRNA levels were determined by a zebrafish oligo microarray. Normalized data are expressed relative to b-actin and from 18
somite to 5 dpf stages. Data represent mean 6 SEM, (n = 3–6 at each stage).
B) ffr is widely expressed in the adult zebrafish. Expression of ffr was determined by RT-PCR. Tissues: Pa, pancreas; Ht, heart; Ad, adipose tissue; Hd: head; Ms; muscle;
In: intestine; Li: liver; Gb, gall bladder.
C) Human ffr and COG8 are widely expressed. Expression was assayed by RT-PCR. Tissues: Ht, heart; Br, brain; Pl, placenta; Lu, lung; Li, liver; SM, skeletal muscle; Ki,
kidney; Pa, pancreas; Sp, spleen; In, small intestine; Co, colon; Le, leucocyte.
D–F) Ffr and COG8 partially colocalize in the Golgi of zebrafish blastomeres. Embryos were coinjected with ffr-gfp mRNA and cog8-mrfpmRNA at the 1- to 4-cell stage.
D) Expression of Ffr-GFP in the perinuclear region.
E) COG8-mRFP localizes primarily to the peripheral Golgi.
F) Merged image of (D) and (E). Arrowheads indicate colocalization of COG8 and Ffr.
G–I)Wild-type (in green) andmutant (in red) Ffr partially colocalize in the cells. (G) Expression of ffrWt-GFP. (H) Expression of ffrmut-mRFP. (I) Merged image of (G) and (H).
Yellow indicates colocalization.
J–L)Mutant Ffr (in red) and clathrin light chain (in green) colocalization. (J) TGNmarker (Clathrin, GFP; pClGFP) (Gaidarov et al., 1999) expression in a single enveloping layer
cell. (K) ffrmut-mRFP expression in a single cell. (L) Merged image of (J) and (K). Yellow indicates truncated Ffr mutant localized in the TGN. The scale bar represents 5 mm.CELL METABOLISM : APRIL 2006 295
A R T I C L EFigure 7. ffr mutants exhibit altered vesicular trafficking and APOA1 targeting
A–F) Histological cross-sections through the intestine of 5 dpf ffr (A–C) and wild-type (D–F) larvae. Red fluorescence shows AM1-43 accumulation in plasma membrane
(arrows) and intracellular vesicles (arrow head) in ffr mutant and wild-type enterocytes. (B and E) Identical sections in (A) and (D) stained with 1% methylene blue in 1%
sodium borate and 1% Azure B (1:1). (C and F) Composites of panels (A) and (B), and (D) and (E), respectively. Note accumulation of AM1-43 in the region of the Golgi
of ffr enteroctyes (C). This is best appreciated in histological cross-sections through the intestine of 5 dpf ffr and wild-type larvae following AM1-43 ingestion and cyclo-
dextran wash to remove noninternalized dye within the plasma membrane (G–J). (K–L) Following ffr ‘‘knockdown’’ by MO-1, the apoA1-mRFP fusion protein had a diffuse
intracellular distribution (arrowhead in [L]), whereas in control embryos the apoA1-mRFP fusion protein was present within vesicles surrounding the nucleus (arrowhead).
The scale bar represents 15 mm.coincided with the size of the Ffr protein in mutant embryos as
determined by Western analyses. Third, knockdown of Ffr pro-
tein by antisense morpholinos generates a ffr phenocopy
whereas injection of ffrmRNA rescued mutant larvae. Together,
these data confirm that the zebrafish ang2 ortholog is in fact the
ffr gene.296Although no human syndrome associated with altered lipid
metabolism has been mapped within the vicinity of the human
ffr ortholog, the established role of vesicle trafficking genes in
human lipid metabolism and the prominent Golgi defects in ffr
mutants argue that this protein is likely to play an important
role in lipid transport in humans.CELL METABOLISM : APRIL 2006
Abnormal lipid trafficking in zebrafish ffr mutantsFfr shares homology with vesicle trafficking proteins
Scanning the predicted ffr amino acid sequence for conserved
sequence motifs (http://myhits.isb-sib.ch/cgi-bin/motif_scan),
we found that the Ffr has a Dor-1 like domain (E = 0.00015)
and a tyrosine phosphorylation site (amino acids 172–179),
which are similar to yeast COG8. The human Ffr ortholog,
ANG2, has previously been noted to have sequence similarities
to yeast COG8 (Whyte and Munro, 2001). In yeast, the cog8
(dor-1) mutation is synthetically lethal when combined with mu-
tations in genes that code for other proteins involved in the Golgi
vesicular trafficking and secretion such as gyp1, hoc1, ypt6, and
arl3 (Tong et al., 2004). Thus, it is conceivable that the Ffr protein
regulates Golgi function through interaction with these or other
genes, either on its own, or in conjunction with the COG com-
plex. The partial colocalization of Ffr and Cog8 fusion proteins
supports this idea, at least in part.
Golgi defects are well described in Tangier disease entero-
cytes and mononuclear phagocytes despite the fact that
ABCA1 protein, which is targeted in this disorder, has been re-
ported to principally localize to plasmamembrane and the endo-
somal system (Neufeld et al., 2001). Thus, it is conceivable that
the Ffr protein functions in some other non-Golgi capacity. Ex-
tra-Golgi localization of the Ffr-GFP fusion protein within perinu-
clear vesicles and the nucleus of zebrafish embryonic cells is
consistent with such a role for Ffr.
Ffr is required for Golgi structure, protein sorting,
and vesicle trafficking
Several lines of evidence show that the Ffr protein is required for
normal Golgi structure and function. First, ultrastructural analy-
ses identified dilated juxtanuclear cisternae in ffrmutant entero-
cytes. Their location strongly supports the identification of the
cisternae as Golgi, as opposed to a multivesicular body or other
endosomal organelle that are typically located in the apical re-
gions of enterocytes and have a distinctive ultrastructural ap-
pearance (Fransen et al., 1985; Klumperman et al., 1991). Sec-
ond, mutant Ffr fusion protein colocalized with clathrin-GFP
(Gaidarov et al., 1999), an established Golgi marker, while the
mutant and wild-type Ffr fusion proteins colocalized with each
other. Third, lipids such as cholesterol and phospholipids, that
are transported as part of lipoprotein particles are metabolized
far less efficiently by ffrmutant larvae than short chain fatty acids
whose absorption is not dependent upon proper lipoprotein par-
ticle assembly (Sheridan, 1988). This is important because lipo-
protein assembly in enterocytes is dependent upon normal
Golgi function.
Themechanism of Golgi biogenesis andmaintenance is com-
plex. A leading model, the cisternal maturation model, posits
that secretory cargo transits the stacks of Golgi cisternae that
mature in situ. As cisternae mature, resident Golgi proteins are
recycled to developing cisternae via retrograde transport within
coat protein complex I (COPI) vesicles, or via intercisternal tu-
bules or simple diffusion (Glick and Malhotra, 1998). A central
question to arise from this study is whether Golgi abnormalities
and subsequent alterations of lipid metabolism in ffr mutants
arise from a defect of anterograde or retrograde Golgi transport.
Such defects could derive from the disruption of the Ffr protein
function within theGolgi itself or from an effect on the biogenesis
of vesicles that traverse the Golgi complex. The partial colocal-
ization of Ffr-GFP and Cog8-mRFP fusion proteins in zebrafish
blastomeres is consistent with the hypothesis that Ffr functionsCELL METABOLISM : APRIL 2006in concert with the COG complex to regulate retrograde Golgi
transport (Ram et al., 2002). Colocalization of the mutant Ffr
mRFP fusion protein with wild-type Ffr-GFP (Figure 6I) and Cla-
thrin-GFP, a well-established TGN marker (Figure 6L), supports
the hypothesis that wild-type Ffr localizes to the TGN. In prelim-
inary experiments, the wild-type Ffr-GFP fusion protein did not
rescue ffrmutants. However, we have yet to determine whether
the Ffr-GFP mRNA encodes a functional protein.
The observation that ApoA1-mRFP was improperly sorted by
ffr morpholino injected blastomeres (Figure 7L) indicates that
Ffr is required for correct protein sorting and anterograde vesic-
ular trafficking. This observation is consistent with mislocaliza-
tion of carboxypeptidase A in the pancreatic exocrine cells of
ffrmutants (Figure 1J). At this time we can only speculate about
the cause of proteinmissorting in ffr deficient cells. However, the
finding that AM1-43 was readily endocytosed by ffr enterocytes
but accumulated in the Golgi, suggests that ApoA1-mRFP mis-
localization in ffr deficient embryos arises from defective traf-
ficking of the ApoA1-mRFP fusion protein through the Golgi
rather than its internalization from the plasmamembrane (Bane-
rjee et al., 1997).
Ffr is required for normal intestinal lipid metabolism
Widespread ffr expression in developing and adult zebrafish
suggests that Ffr plays a role in most tissues. Thus, it is surpris-
ing that ffrmutants have a pronounced defect of digestive organ
function, whereas the development and presumed function of
other tissues is normal. Several explanations may account for
these findings. First, Ffr may be essential for cellular trafficking
in other organs. Histological and ultrastructural assays may
not be sensitive enough to document these defects. Second,
the ffr mutation may not completely abolish the function of the
truncated Ffr protein. This possibility coupled with the late de-
cline in ffr expression and the large amount of maternal ffr tran-
scripts could explain organ-specific defects in ffrmutants. Third,
if Ffr functions in sorting specific classes of proteins, such as
apolipoproteins and peptidases (which are both mislocalized
in ffr-deficient embryos), it is conceivable that the digestive or-
gan Golgi defects are more pronounced due to the higher de-
mand for sorting these proteins (classes) in these organs.
Fourth, the Drosophila COG5 mutation only exhibits Golgi de-
fects in spermatocytes (Farkas et al., 2003), providing an exam-
ple of a mutation in an ubiquitously expressed COG gene that
results in a tissue specific defect.
Altered lipid metabolism in ffr mutant larvae is likely to arise
from defects in multiple organs. Biliary degeneration undoubt-
edly impairs bile secretion and secondarily the emulsification
of dietary lipids and their absorption by enterocytes. Golgi de-
fects are likely to interfere with the transport of lipids in lipopro-
tein particles by enterocytes into the lymphatics. Consistent
with these proposed defects, ffr mutants processed a fluores-
cent short chain fatty acid analog normally (Farber et al.,
2001). This latter finding is noteworthy because short chain fatty
acids absorbed by enterocytes are bound to albumin and se-
creted directly into the portal bloodstream rather than being in-
corporated into lipoprotein particles and secreted into the lym-
phatic system (after traversing the Golgi). Normal processing
of short chain fatty acids may imply that Golgi-mediated lipid
transport, rather than luminal absorption, is the primary defect
within the ffrmutant intestine. However, it is conceivable that al-
tered Golgi function in ffr mutants affects localization of297
A R T I C L Etransporters specifically required for cholesterol and phospho-
lipids absorption (Albers and Cheung, 2004; Field, 2001).
In conclusion, we have identified a mutation in zebrafish, ffr,
which causes impaired lipid processing in the digestive system.
The positional cloning and in vivo analyses showed Ffr is a new
member of the Dor-1 like family. Altered Golgi morphology in ffr
mutants indicates this protein plays an important role in Golgi
structure, Golgi-associated protein secretion or vesicular recy-
cling. The expanded subcellular distribution of Ffr fusion protein
compared with another Dor-1 family member, COG8, suggest
additional cellular roles for Ffr protein.
Experimental procedures
Histology and immunohistochemistry
Wild-type and ffr mutant larvae were fixed in 4% paraformaldehyde at 4ºC
overnight or in MeOH/DMSO (4/1) for 2 hr at room temperature. In some
cases, specimens were washed and embedded in glycol methacrylate (JB-
4 Plus, Polysciences). Sections and immunohistochemistry were performed
as previously described (Lorent et al., 2004; Pack et al., 1996).
Map cross and mutant collections.
Themale *AB founder fishweremutagenizedwith ethylnitrosourea (ENU) and
screened for lipid processing as previously described (Driever et al., 1996;
Farber et al., 2001). The F2 heterozygous ffr were out crossed to TLF strain
to create amap cross. The offspring of heterozygous ffr parents were labeled
with PED6 and screened at 5 dpf to identify mutant larvae. Genomic DNAwas
isolated from individual mutant larvae and utilized for positional cloning
efforts.
Bulk segregant and linkage analysis
The ffr locus was initially mapped to linkage group 10 (marker z6183) using
bulk segregant analysis (Rawls et al., 2003) performed using two samples
of pooled genomic DNA obtained from 20 wild-type and 20 ffr mutant lar-
vae. More than 2000 mutants were collected to perform the subsequent link-
age and recombinant analyses. Potential markers were tested using the
pooled DNA to determine if they were polymorphic using high resolution
2% metaphor agarose gels. Specific polymorphic markers were then ampli-
fied with PCR using genomic DNA of individual mutant larvae. The total num-
ber of recombinants (typically revealed as a doublet following PCR) were
used to calculate the meiotic distance of specific markers from the ffr locus
(Dicarprio and Hastings, 1976). In some cases, the PCR products generated
by fluorescent primers for a particular marker were run on acrylamide gels
and scanned (GeneScan, ABI 377) to identify polymorphisms that cannot
be resolved using agarose (<10 bp). All informative markers were mapped
on radiation hybrid panels (LN54 and T51) even if their location was previ-
ously determined by other laboratories to more precisely order markers in
reference to the ffr critical region.
Cloning of zebrafish ffr, COG8, and ApoAI
The zebrafish ffr was cloned using primers 50-ACA TCT GTC ATT CAT TCA
TTT AAT AAT TC-30 and 50-CTA TCC CCT CTC ACA GAT GAC TTC-30. The
zebrafish COG8 was cloned using primers 50-ATG GCT GCC GTA GAC
GTG GAA GA-30 and 50-ATA ATA ATC TTC ACA AAA CAA AGT TGT TG-30.
The ApoAI was cloned using primers 50-A TGA AAT TCG TGG CTC TTG
CA-30 and 50-TGC CTG GAT GGC CTT GGC-30. All three PCR products
were cloned using PCRIITOPO (Invitrogen).
Morpholino injection and phenotypic rescuing
Embryos at 1- to 4-cell stage were injected (1–2 nl) with mRNA or MOs using
glass microelectrodes fitted to a gas pressure injector (PL1-100, Harvard Ap-
paratus). Electrodeswere pulled (P-97, Flaming/Brown) and filledwith a stock
solution of MOs targeted to the ffr gene (1–2 mM, Gene Tools) or mRNA of ffr
(1 mg/ml). Phenol red solution (0.2% final concentration) was added to all in-
jection solutions to visualize injected embryos. MO4 injected morphants
were collected at 4 dpf to isolate total RNA (TriZol). After reverse transcrip-
tion, PCR was performed with primers 50-AGA AGA TGG AGG ATG AAA
TGG A-30 and 50-AAC AGG AAC TGC AGT TTT CGG AGA A-30. For rescue298experiments, embryos from heterozygous ffr parents were injected with ei-
ther water or ffrmRNA at 1-4 cell stages and then labeled either with fluores-
cent cholesterol or PED6 at 5 dpf. Individual zebrafish larvae were then pho-
tographed to capture total gut fluorescence, which was digitally quantified
(Image Quant TL, Amersham Biosciences Corp) and then genotyped using
PCR with a closely linked marker (Z54342).
Domain analysis and transcriptional profiling
Domain analysis was performed using the prosite database of protein fami-
lies and domains (http://us.expasy.org/prosite/). Transcriptional profiling
was performed by the Thomas Jefferson University Microarray Facility at
the Kimmel Cancer Center. The spotted array contains 16,399 oligos (Com-
pugen Inc.,). More than 100 b-actin oligos that serve as positive controls were
on each chip. Total RNA of 4 dpf and 5 dpf wild-type and ffr larvae were ex-
tracted by TriZol (Invitrogen). Gene expression was determined using biotin-
labeled and in vitro-transcribed antisense RNA generated from the total RNA
template. Each chip was scanned and quantified using a ScanArray Express
laser scanner (Perkin Elmer). The signals on the oligo microarray were nor-
malized by themedian and regularized t test was performed to determine sig-
nificant differences between the wild-type and ffr mutants.
RT-PCR for zebrafish and human ffr and human COG8
The human cDNA from a variety of tissues was commercially obtained (BD
Biosciences) and used to examine ffr and COG8 expression by PCR. ffr
primers were 50-CAC CAT CCG GAA GAT GAA GAA CGA-30 and 50-AAC
GAG GGC AGG TGT TGG TAC TG-30, and COG8 primers were 50-TCA
TGG ACA CCT GTG TCC GGA AC-30 and 50-TGG CAC GGT ACT GGG
TGA TGA TAT-30. Adult zebrafish were dissected to collect different tissues
and total RNA was prepared (TriZol). The first strand cDNA was prepared
by reverse transcription. PCR was performed using primers 50-ATT ACT
CCC GGG GTC GGC AGT G-30 and 50-TGT GAG CGT GAG GAT GTA
GGA GAT-30.
Plasmid constructions and mRNA preparation
The pT3Ts plasmid was obtained from Dr. S. Ekker (University of Minnesota).
Plasmid containing monomeric red fluorescent protein (mRFP) was obtained
fromDr. Tsien (Campbell et al., 2002) andwas subcloned into the pT3Ts plas-
mid to make pT3mRFP. Zebrafish ffr transcript was subcloned between the
SpeI and BstEII sites of pT3GFP. Zebrafish COG8 and ApoAI were subcloned
into pT3mRFP to make COG8-mRFP and APOAI -mRFPconstructs. mRNA
of zffr-GFP, zCOG8-mRFP and zAPOAI-mRFP was prepared by mMES-
SAGE mMACHINE (Ambion Inc).
Subcellular localization of ffr, COG8 and ApoAI
1- to 4-cell stage embryos were coinjected with mRNA of GFP or mRFP fu-
sion constructs of ffr, COG8, and ApoAI. PBD Living Colors TM fluorescent
proteins plasmid vectors that mark nucleus, Golgi, ER, and plasma mem-
brane (BD Biosciences) were also injected into embryos at 1- to 4-cell stage.
TGN marker pCleGFP was provided by Dr. J. Keen (Thomas Jefferson Uni-
versity). Embryos (24 hpf) were then fixed in 4% paraformaldehyde overnight
at 4ºC and then transferred toPBS. Confocal imageswere taken using a Zeiss
LSM 510 META.
AM1-43 feeding experiments
5 dpf wild-type and ffrmutants were immersed into embryomedium contain-
ing 20mMAM1-43 (Biotium, Inc.) for 2 hr at 28ºC. Then the larvae were trans-
ferred into embryo medium containing ADVASEP-7 (a sulfonated b-cyclo-
dextrin, Biotium, Inc.) (100 mM for 1 hr at 28ºC). The larvae were fixed in
4% paraformaldehyde overnight at 4ºC, embedded in plastic, and sectioned
(1 mM). Some sections were labeled with 1% methylene blue in 1% sodium
borate and 1% Azure B (1:1). Confocal images were taken using a Zeiss
LSM510 META.
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